Jitendra Mohan Sells 10,188 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan sold 10,188 shares of the company’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.45, for a total value of $1,787,484.60. Following the completion of the sale, the chief executive officer directly owned 4,069,134 shares in the company, valued at $713,929,560.30. This trade represents a 0.25% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

• On Friday, April 17th, Jitendra Mohan sold 325,693 shares of Astera Labs stock. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02.
• On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The shares were sold at an average price of $174.60, for a total value of $518,038.20.
• On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The shares were sold at an average price of $149.68, for a total value of $18,522,900.00.
• On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.
• On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51.

Astera Labs Price Performance

Astera Labs stock traded up $16.17 during trading hours on Tuesday, hitting $191.97. The stock had a trading volume of 10,826,250 shares, compared to its average volume of 4,676,736. The stock has a market capitalization of $32.87 billion, a price-to-earnings ratio of 162.78, a PEG ratio of 3.46 and a beta of 1.78. Astera Labs, Inc. has a 1-year low of $54.54 and a 1-year high of $262.90. The stock’s fifty day moving average is $129.60 and its two-hundred day moving average is $153.55.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue was up 91.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 1.48 EPS for the current year.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Lido Advisors LLC lifted its position in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Perigon Wealth Management LLC lifted its position in Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares during the period. Clearstead Advisors LLC lifted its position in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares during the period. Sound Income Strategies LLC lifted its position in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares during the period. Finally, Venturi Wealth Management LLC lifted its position in Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ALAB. Barclays set a $165.00 price objective on Astera Labs in a research report on Thursday, January 15th. Royal Bank Of Canada restated an “outperform” rating and issued a $250.00 price objective on shares of Astera Labs in a research report on Tuesday. Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective on the stock. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Finally, UBS Group began coverage on Astera Labs in a research report on Tuesday. They issued a “neutral” rating and a $180.00 price objective on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $199.74.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Large customer/collar‑partner news in the AI ecosystem is lifting demand expectations for Astera’s connectivity chips; the Amazon–Anthropic announcement helped lift related suppliers including Astera. Astera Labs and Marvell Stocks Climb. Thank Amazon and Anthropic.
• Positive Sentiment: Analyst/market commentary frames Astera as a “tollbooth” for AI infrastructure — its Aries retimers and CXL/PCIe positioning are seen as essential to scaling GPUs and reducing data‑traffic bottlenecks, supporting a long growth runway and premium margins. Astera Labs: The Tollbooth for AI’s Traffic Jam
• Positive Sentiment: Fund interest and bullish writeups (Yahoo/other outlets) highlight Astera as a hedge‑fund darling and a fast‑growing supplier to hyperscalers — reinforcing momentum and heavier trading volumes. Astera Labs Inc. (ALAB): Hedge Fund Darling Is Solving Compute Bottlenecks
• Neutral Sentiment: Technical/pattern traders are flagging ALAB as one of a few stocks showing a buy signal after recent market moves — this can amplify momentum but is not a fundamental catalyst by itself. 3 Stocks Flashing Rare Buy Signals After the Market’s Wildest Month (ALAB)
• Neutral Sentiment: Comparative coverage weighing Astera vs. peers (Credo/Marvell) highlights different growth and M&A dynamics — useful context for valuation and competitive risk but not an immediate price driver. CRDO vs. ALAB: Which High Speed Connectivity Stock Is the Smarter Buy?
• Negative Sentiment: Director Stefan Dyckerhoff sold multiple blocks of ALAB stock this week (several Form 4 filings). The aggregate sales are material in size, which can create short‑term selling pressure or raise governance questions — though the company notes these were executed under pre‑arranged Rule 10b5‑1 plans. Insider Form 4 Filings (Dyckerhoff)

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.